Expand ABCL Menu

ABCL Stock Summary and Trading Ideas (Abcellera Biologics - Common Shares | NASDAQ:ABCL)

Charts for Today's Stock Price and Implied Volatility in Abcellera Biologics - Common Shares


Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for ABCL by Theoretical Edge and Win Rates


Trading Statistics

Key Ratios

Abcellera Biologics - Common Shares (ABCL) Frequently Asked Questions

What does Abcellera Biologics - Common Shares do?

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

What symbol and exchange does Abcellera Biologics - Common Shares stock trade?

Abcellera Biologics - Common Shares trades on the NASDAQ stock market under the symbol ABCL.

What is Abcellera Biologics - Common Shares stock price doing today?

As of July 24, 2024, ABCL stock price declined to $3.01 with 1,048,326 million shares trading.

What is Abcellera Biologics - Common Shares's Beta?

ABCL has a beta of 1.73, meaning it tends to be more sensitive to market movements. ABCL has a correlation of 0.15 to the broad based SPY ETF.

How much is Abcellera Biologics - Common Shares worth?

ABCL has a market cap of $885.10 million. This is considered a Small Cap stock.

How much money does Abcellera Biologics - Common Shares make?

Last quarter Abcellera Biologics - Common Shares reported $10 million in Revenue and -$.14 earnings per share. This fell short of revenue expectation by $-886,000 and exceeded earnings estimates by $.03.

What is the highest and lowest price Abcellera Biologics - Common Shares traded in the last 3 year period?

In the last 3 years, ABCL stock traded as high as $22.63 and as low as $2.65.

What are the top ETFs holding Abcellera Biologics - Common Shares?

The top ETF exchange traded funds that ABCL belongs to (by Net Assets): IBB, IDNA, SPDW, ONEQ, GWX.

Is Abcellera Biologics - Common Shares (ABCL) a good investment?

ABCL has underperformed the market in the last year with a return of -60.7%, while the SPY ETF gained +20.7%. In the last 3 month period, ABCL fell short of the market, returning -22.8%, while SPY returned +7.4%. However, in the most recent 2 weeks ABCL has outperformed the stock market by returning +7.5%, while SPY returned -2.6%.

What is the support and resistance for Abcellera Biologics - Common Shares (ABCL) stock price?

ABCL support price is $2.97 and resistance is $3.24 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ABCL stock will trade within this expected range on the day.